Status:
COMPLETED
Neuromuscular Stimulation Versus Intermittent Compression for Venous Thromboembolism Prophylaxis in Critical Care
Lead Sponsor:
Manchester University NHS Foundation Trust
Collaborating Sponsors:
Firstkind Ltd
Manchester Academic Health Science Centre
Conditions:
Critical Illness
Sepsis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this prospective, randomised, open-label, parallel group, feasibility trial; the investigators will objectively assess whether it is feasible to apply the Geko device to critically ill adults for t...
Detailed Description
VTE is a common problem amongst patients in critical care. Current measures include intermittent pneumatic compression devices, used to aid the venous return of blood from the lower limbs. These devic...
Eligibility Criteria
Inclusion
- Male or female aged ≥ 18 years.
- Intact healthy skin at the proposed site of gekoTM device application.
- Within 24 hours of their admission to critical care
- Expected to remain in critical care until the day after tomorrow
Exclusion
- Use of any concurrent neuro-modulation drug or device (e.g. neuromuscular blocking agents).
- Trauma to the lower limbs that would prevent geko™ from stimulating the common peroneal nerve.
- Inability to palpate the fibula head in order to apply geko device effectively
- Inability to obtain valid written consent from the participant or their designated legal representative
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05208216
Start Date
November 1 2022
End Date
May 1 2024
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester Royal Infirmary
Manchester, United Kingdom, M13 9WL